OpenVSafe by OpenVAERS
Search V-safe

YK6-15878-79476

2 vaccinations 2 coded responses 7 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
370 / TN
Registered
2021-04-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-29
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-20
    Registered in v-safe
  3. 2021-04-20
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-20
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  5. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness
    Adult check-in
  6. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-07-20
    Survey response — 3 months, dose 2
    MedDRA: Heavy menstrual bleeding — Feeling: Good
    Free text: Heavy and long periods
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-10-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  10. 2022-04-20
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: 3 miscarriages
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-04-20
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  12. 2022-04-22
    Call successful
    Does not wish to fill out VAERS report

Vaccinations

DoseDateManufacturerCo-administered
12021-03-29Pfizer-BioNTech
22021-04-20Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2022-04-20 Successful
2022-04-22
Does not wish to fill out VAERS report

Free text

Release 9 — 3 months, dose 2

2021-07-20

Symptoms: Heavy and long periods

Release 11 — 12 months, dose 2

2022-04-20

Symptoms: 3 miscarriages

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDHeavy menstrual bleeding · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release